Biomarkers in Alzheimer s Disease

Biomarkers in Alzheimer’s Disease provides a comprehensive overview of all modalities of Alzheimer’s disease biomarkers, including neuroimaging, cerebrospinal fluid, genomic, and peripheral systems. Each chapter integrates molecular/cellular abnormality due to Alzheimer’s disease and technological advancement of biomarkers techniques. The book is ideal for clinical neuroscience and molecular/cellular neuroscience researchers, psychiatrists, and allied healthcare practitioners involved in the diagnosis and management of patients with cognitive impairment and Alzheimer’s disease, and for differential diagnosis of Alzheimer’s disease with other non-Alzheimer’s dementia. Presents a comprehensive overview detailing all modalities of Alzheimer’s disease biomarkers Written for neuroscience researchers and clinicians studying or treating patients with Alzheimer’s Disease Integrates, in each chapter, the molecular/cellular abnormality due to Alzheimer’s disease and the technological advancement of biomarkers techniques

Produk Detail:

  • Author : Tapan Khan
  • Publisher : Academic Press
  • Pages : 276 pages
  • ISBN : 0128051477
  • Rating : 4/5 from 21 reviews
CLICK HERE TO GET THIS BOOKBiomarkers in Alzheimer s Disease

Biomarkers in Alzheimer's Disease

Biomarkers in Alzheimer's Disease
  • Author : Tapan Khan
  • Publisher : Academic Press
  • Release : 02 August 2016
GET THIS BOOKBiomarkers in Alzheimer's Disease

Biomarkers in Alzheimer’s Disease provides a comprehensive overview of all modalities of Alzheimer’s disease biomarkers, including neuroimaging, cerebrospinal fluid, genomic, and peripheral systems. Each chapter integrates molecular/cellular abnormality due to Alzheimer’s disease and technological advancement of biomarkers techniques. The book is ideal for clinical neuroscience and molecular/cellular neuroscience researchers, psychiatrists, and allied healthcare practitioners involved in the diagnosis and management of patients with cognitive impairment and Alzheimer’s disease, and for differential diagnosis of Alzheimer’

Update on Dementia

Update on Dementia
  • Author : Davide Moretti
  • Publisher : BoD – Books on Demand
  • Release : 28 September 2016
GET THIS BOOKUpdate on Dementia

The dementia challenge is the largest health effort of the times we live in. The whole society has to move to a realization of the significance of prioritization to make an attempt in the direction of mental health promotion and dementia risk reduction. New priorities for research are needed to go far beyond the usual goal of constructing a disease course-modifying medication. Moreover, a full empowerment and engagement of men and women living with dementia and their caregivers, overcoming stigma

Biomarkers of Alzheimer's Disease: The Present and the Future

Biomarkers of Alzheimer's Disease: The Present and the Future
  • Author : Sylvain Lehmann,Charlotte Elisabeth Teunissen
  • Publisher : Frontiers Media SA
  • Release : 10 November 2016
GET THIS BOOKBiomarkers of Alzheimer's Disease: The Present and the Future

Alzheimer disease (AD) is a neurodegenerative disorder characterized by significant cognitive deficits, behavioral changes, sleep disorders and loss of functional autonomy. AD represents the main cause of dementia and has become a major public health issue. In addition, the number of patients suffering from AD is growing rapidly as the population ages worldwide. Memory impairment is usually the earliest clinical and core symptom of this disease. The diagnosis at a late clinical stage is relatively easy. However, a delay in

The Right Therapy for Neurological Disorders

The Right Therapy for Neurological Disorders
  • Author : E. Beghi,G. Logroscino
  • Publisher : Karger Medical and Scientific Publishers
  • Release : 26 July 2016
GET THIS BOOKThe Right Therapy for Neurological Disorders

Most neurological disorders are chronic and aging-related. With the increase of life expectancy their incidence and prevalence will grow in the decades to come, which in turn will increase the load on medical and social systems worldwide. There is thus a desperate need for successful preventive and therapeutic measures based on randomized clinical trials (RTCs) conducted by independent organizations. This book provides a compendium relating most of the principles of reliable RTCs to specific neurological diseases. Contributed by specialized neurologists,

Biomarkers for Preclinical Alzheimer’s Disease

Biomarkers for Preclinical Alzheimer’s Disease
  • Author : Robert Perneczky
  • Publisher : Humana Press
  • Release : 27 February 2018
GET THIS BOOKBiomarkers for Preclinical Alzheimer’s Disease

This volume discusses the importance of imaging, fluid, and genetic biomarkers in detecting the earliest pre-symptomatic stages of Alzheimer’s disease (AD). The chapters in this book are separated into five parts. Part one explores the reasons why we need improved approaches for early detection and diagnosis of AD. Part two describes clinical and research techniques for preclinical AD diagnosis. Part three looks at the current methods in use to diagnose AD and how they can also be used for

Biological Markers of Alzheimer’s Disease

Biological Markers of Alzheimer’s Disease
  • Author : Francois Boller,Robert Katzman,Andre Rascol,Jean-Louis Signoret
  • Publisher : Springer Science & Business Media
  • Release : 08 March 2013
GET THIS BOOKBiological Markers of Alzheimer’s Disease

This volume presents the proceedings of the symposium held in Toulouse on April 24, 1989, on the topic "Biological Markers of Alzheimer's Disease. " This sym posium was the fourth of a continuing and successful series of Colloques Medecine et Recherche organized by the Fondation IPSEN pour la Recherche Therapeutique, addressing various aspects of contemporary research in the field of Alzheimer's disease (AD). The series started in September 1987 with "Im munology and Alzheimer's Disease," followed 6 months later in Paris by "Gene tics and

Proteomic Methods in Neuropsychiatric Research

Proteomic Methods in Neuropsychiatric Research
  • Author : Paul C. Guest
  • Publisher : Springer
  • Release : 22 March 2017
GET THIS BOOKProteomic Methods in Neuropsychiatric Research

Due to continuous technical developments and new insights into the high complexity of neurological diseases, there is an increasing need for the application of proteomic technologies which can yield potential biomarker readouts for improved clinical management as well as for the development of new drugs by struggling pharmaceutical companies. This book describes the step-by-step use of proteomic methods such as two-dimensional gel electrophoresis, multiplex immunoassay, liquid chromatography mass spectrometry (LC-MS) and selective reaction monitoring MS, to increase our understanding of

Amyloid Proteins

Amyloid Proteins
  • Author : Einar M. Sigurdsson
  • Publisher : Springer Science & Business Media
  • Release : 30 July 2021
GET THIS BOOKAmyloid Proteins

A proven collection of readily reproducible techniques for studying amyloid proteins and their involvement in the etiology, pathogenesis, diagnosis, and therapy of amyloid diseases. The contributors provide methods for the preparation of amyloid and its precursors (oligomers and protofibrils), in vitro assays and analytical techniques for their study, and cell culture models and assays for the production of amyloid proteins. Additional chapters present readily reproducible techniques for amyloid extraction from tissue, its detection in vitro and in vivo, as well

Developing Therapeutics for Alzheimer's Disease

Developing Therapeutics for Alzheimer's Disease
  • Author : Michael S. Wolfe
  • Publisher : Academic Press
  • Release : 27 May 2016
GET THIS BOOKDeveloping Therapeutics for Alzheimer's Disease

Developing Therapeutics for Alzheimer's Disease: Progress and Challenges provides a thorough overview of the latest advances toward the development of therapeutics for Alzheimer’s disease, along with the major hurdles that still must be overcome and potential solutions to these problems. Despite the lack of progress toward developing therapeutics that can slow or stop the progression of this disease, important discoveries have been made and many promising approaches are advancing in preclinical studies and clinical trials. This book outlines the

Sex and Gender Differences in Alzheimer's Disease

Sex and Gender Differences in Alzheimer's Disease
  • Author : Maria Teresa Ferretti,Annemarie Schumacher Dimech,Antonella Santuccione Chadha
  • Publisher : Academic Press
  • Release : 05 August 2021
GET THIS BOOKSex and Gender Differences in Alzheimer's Disease

Sex and Gender Differences in Alzheimer’s Disease: The Women's Brain Project offers, for the first time, a critical overview of the evidence documenting sex and gender differences in AD neurobiology, biomarkers, clinical presentation, treatment, clinical trials and their outcomes and impact on caregivers. This knowledge is crucial for clinical development, digital health solutions, and as social and psychological support to AD families. Presents comprehensive and critical reviews of sex differences in Alzheimer’s disease Combines the knowledge and points-of-view

Early Diagnosis of Alzheimer’s Disease

Early Diagnosis of Alzheimer’s Disease
  • Author : Leonard F. M. Scinto,Kirk R. Daffner
  • Publisher : Springer Science & Business Media
  • Release : 09 February 2000
GET THIS BOOKEarly Diagnosis of Alzheimer’s Disease

Drs. Leonard Scinto and Kirk Daffner provide a comprehensive survey of new diagnostic approaches to Alzheimer's disease. The authoritative contributors critically survey the most promising current research on early diagnostic markers for Alzheimer's disease, including the elucidation of changes in the brain revealed by structural and functional neuroimaging, as well as the characteristic patterns of cognitive decline that are documented by sensitive neuropsychological tests, various genetic markers, and biological assays. Early Diagnosis of Alzheimer's Disease illuminates the complex issues surrounding

Neuropsychiatric Disorders

Neuropsychiatric Disorders
  • Author : Manfred Gerlach,Jürgen Deckert,Kay Double,Eleni Koutsilieri
  • Publisher : Springer Science & Business Media
  • Release : 28 December 2007
GET THIS BOOKNeuropsychiatric Disorders

This multidisciplinary book includes current research papers and reviews in the areas of basic neuroscience, neural mechanisms underlying neurodegenerative disorders. It further includes new approaches for neuroprotective treatments, clinical, neurobiological and treatment aspects of psychiatric disorders. The book was conceived as a celebration of the professional life and work of Peter Riederer to mark the occasion of his retirement.

Neurochemical Aspects of Alzheimer's Disease

Neurochemical Aspects of Alzheimer's Disease
  • Author : Akhlaq A. Farooqui
  • Publisher : Academic Press
  • Release : 25 May 2017
GET THIS BOOKNeurochemical Aspects of Alzheimer's Disease

Neurochemical Aspects of Alzheimer's Disease provides a comprehensive overview of molecular aspects of risk factors, pathogenesis, biomarkers, and therapeutic strategies. The book focuses on molecular mechanisms and signal transduction processes associated with the pathogenesis, biomarkers, and therapeutic strategies of AD. The comprehensive and cutting edge information in this monograph may not only help in early detection of AD, but also promote discovery of new drugs to treat this chronic disease. Chapters discuss involvement of neural membrane phospholipids, sphingolipids, and cholesterol-derived

Neurodegenerative Diseases

Neurodegenerative Diseases
  • Author : Philip Beart,Michael Robinson,Marcus Rattray,Nicholas J. Maragakis
  • Publisher : Springer
  • Release : 21 July 2017
GET THIS BOOKNeurodegenerative Diseases

Provides a timely overview of critical advances in molecular and cellular neurobiology, covers key methodologies driving progress, and highlights key future directions for research on neuronal injury and neurodegeneration relevant to neuronal brain pathologies. The editors bring together contributions from internationally recognized workers in the field to provide an up to date account of how and why molecular and cellular neurobiology is such an important area for clinical neuroscience. Understanding the molecular aspects of a number of neurodegenerative conditions such